ChitraHosingMD

PubMed

• Autologous non-myeloablative hematopoietic stem cell transplantation for diffuse cutaneous systemic sclerosis: identifying disease risk factors for toxicity and long-t...
  George E Georges, Dinesh Khanna, Mark H Wener, Matthew G Mei, Maureen D Mayes
  Arthritis & Rheumatology. 2024-12-03
• High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas.
  Jeremy Ramdial, Ruitao Lin, Peter F Thall, Benigno C Valdez, Chitra Hosing
  Bone Marrow Transplantation. 2024-12-01
• On the Way to Curing Advanced-Stage Mycosis Fungoides/Sézary Syndrome.
  Seda Purnak, Chitra Hosing, Bouthaina Dabaja, Roland L Bassett, Auris Huen
  Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01

Journal Articles

• Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...  
  Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature
• Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...  
  Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature
• Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers  
  Ravi Murthy, Robert S Benjamin, Anthony P Conley, Chitra Hosing, David S Hong, Aung Naing, Clinical Cancer Research

Abstracts/Posters

• Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
  Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Optimizing the Use of Platelets in a Single Oncology Center during Critical Shortages: Can Current Platelet Donations from Volunteer Donors be Sustained to Provide Ade...
  Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
  Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
  Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis
  Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase I/II Study to Examine the Safety and Efficacy of Pembrolizumab 200 Mg Fixed Dose Administered Every 3 Weeks (Q3W) in Combination with Romidepsin in Relapsed or...
  Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation
  Chitra Hosing, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Hematopoietic Cell Transplant -Composite Risk (HCT-CR) - a Novel Prognostic Model to Predict Transplant Outcomes 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all